Amgen
Search results
2 days ago · “As the most comprehensive and diverse HIV prevention trial program ever conducted, the PURPOSE program embodies both the scientific and person-centered innovations that Gilead believes are critical to help end the HIV epidemic for everyone, everywhere,” said Jared Baeten, MD, PhD, Senior Vice President, Clinical Development and HIV Franchise Head, Gilead Sciences.
- Careers at Gilead
Equal Opportunities . As an equal opportunity employer,...
- Medicines
Gilead is committed to helping improve the lives of people...
- U.S. Locations
The Gilead office in Miami, Fla., is home to members of the...
- Pipeline
Learn about the investigational medicines in Gilead's...
- Contact Us
For Kite Medical Information, Clinical Trial Inquiries,...
- Newsroom
Full Efficacy and Safety Results for Gilead Investigational...
- Careers at Gilead
2 days ago · Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
2 days ago · Gilead Sciences is a sizable biopharmaceutical player with a portfolio of drugs that treat life-threatening diseases like HIV, viral hepatitis, and cancer. Over the trailing 12 months, GILD ...
4 days ago · Jul. 22, 2024, 12:00 PM. Gilead Sciences (NASDAQ:GILD) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a ...
Jul 16, 2024 · PURPOSE 1 is the first HIV prevention trial to intentionally include pregnant and lactating women. In June, the topline results from an interim analysis of the Phase 3 trial were announced, demonstrating 100% efficacy for the investigational use of HIV prevention in cisgender women.
2 days ago · Gilead Sciences is a biopharmaceutical company that develops and markets therapies for HIV, hepatitis, oncology, and other diseases. Get the latest stock price, news, ratings, valuation, and financials for GILD on Morningstar.
Jul 17, 2024 · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
